Alvotech

9.55+1.34+16.32%Vol 83.11K1Y Perf -
Jul 1st, 2022 16:00 DELAYED
BID5.15 ASK10.50
Open8.00 Previous Close8.21
Pre-Market- After-Market9.98
 - -  0.43 4.50%
Target Price
22.00 
Analyst Rating
Strong Buy 1.00
Potential %
130.37 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
26.39 
Earnings Rating
Market Cap2.01B 
Earnings Date
-
Alpha Standard Deviation
Beta 

Today's Price Range

8.0010.57

52W Range

7.9414.04

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
8.03%
1 Month
-
3 Months
-
6 Months
-
1 Year
-
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ALVO9.551.340016.32
AAPL138.932.21001.62
GOOG2 181.62-5.8300-0.27
MSFT259.582.75001.07
XOM87.551.91002.23
WFC39.920.75001.91
JNJ179.522.01001.13
FB196.640.99000.51
GE63.54-0.1300-0.20
JPM114.051.44001.28
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume83.11K
Shares Outstanding210.60K
Shares Float210.60M
Trades Count936
Dollar Volume759.13K
Avg. Volume62.34K
Avg. Weekly Volume44.55K
Avg. Monthly Volume71.24K
Avg. Quarterly Volume71.24K

Alvotech (NASDAQ: ALVO) stock closed at 9.55 per share at the end of the most recent trading day (a 16.32% change compared to the prior day closing price) with a volume of 83.11K shares and market capitalization of 2.01B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 0 people. Alvotech CEO is .

The one-year performance of Alvotech stock is %, while year-to-date (YTD) performance is %. ALVO stock has a five-year performance of %. Its 52-week range is between 7.94 and 14.04, which gives ALVO stock a 52-week price range ratio of 26.39%

Alvotech currently has a PE ratio of -18.30, a price-to-book (PB) ratio of -, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -18.93%, a ROC of -% and a ROE of 20.24%. The company’s profit margin is -%, its EBITDA margin is -49.00%, and its revenue ttm is $0.00 , which makes it $- revenue per share.

Of the last four earnings reports from Alvotech, there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Alvotech’s next earnings report date is -.

The consensus rating of Wall Street analysts for Alvotech is Strong Buy (1), with a target price of $22, which is +130.37% compared to the current price. The earnings rating for Alvotech stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Alvotech has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Alvotech has a Neutral technical analysis rating based on Technical Indicators (), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Alvotech in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (100.00 %)
1 (100.00 %)
1 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

Alvotech

Alvotech is a integrated biopharmaceutical company committed to developing and manufacturing high quality biosimilar medicines for patients globally. The company's purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.

CEO:

Telephone: +352 4224500

Address: 9, rue de Bitbourg, Luxembourg L-1273, , LU

Number of employees: 0

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits